The study examined 29 patients who received the Regeneten implant and 28 patients who did not after a rotator cuff repair, according to a Sept. 14 company news release. Retear rates for those in the implant group was 3.5 percent at the 12-month follow-up and 25 percent in the group that did not have the Regeneten implant.
There were no differences in postoperative complications between the groups, according to the study.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
